Fig. 4From: Transcatheter arterial chemoembolization plus sorafenib versus transcatheter arterial chemoembolization alone to treat advanced hepatocellular carcinoma: a meta-analysisForest plot comparing overall survival (OS). CI, confidence interval; OR, odds ratio; Combination group, TACE + sorafenib; and Control group, TACE aloneBack to article page